Cargando…

Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers

The management of non-small cell lung cancer (NSCLC) has transformed with the discovery of therapeutically tractable oncogenic drivers. In addition to activating driver mutations, gene fusions or rearrangements form a unique sub-class, with anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Aaron C., Itchins, Malinda, Khasraw, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073114/ https://www.ncbi.nlm.nih.gov/pubmed/32093103 http://dx.doi.org/10.3390/ijms21041416

Ejemplares similares

The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine
por: Itchins, Malinda, et al.
Publicado: (2022)

A sociology of precision‐in‐practice: The affective and temporal complexities of everyday clinical care
por: Kenny, Katherine, et al.
Publicado: (2021)

Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases
por: Tan, Aaron C., et al.
Publicado: (2022)

Breakthrough 5-year survival with pembrolizumab in Keynote-001 study: horizon shifting in advanced non-small cell lung cancer with immune check point inhibition
por: de Silva, Madhawa, et al.
Publicado: (2020)

The microenvironment of brain metastases from solid tumors
por: Srinivasan, Ethan S, et al.
Publicado: (2021)

Hope in the era of precision oncology: a qualitative study of informal caregivers’ experiences
por: Kenny, Katherine, et al.
Publicado: (2023)

Cystic brain metastases and RET fusion in lung cancer
por: Remon, Jordi, et al.
Publicado: (2020)

Targeted drugs for systemic therapy of lung cancer with brain metastases
por: Sun, Ya-Wen, et al.
Publicado: (2017)

Brain Metastases from Lung Cancer: Is MET an Actionable Target?
por: Stella, Giulia M., et al.
Publicado: (2019)

Comparative Efficacy of Systemic Agents for Brain Metastases From Non-Small-Cell Lung Cancer With an EGFR Mutation/ALK Rearrangement: A Systematic Review and Network Meta-Analysis
por: Taslimi, Shervin, et al.
Publicado: (2021)

Emerging Lung Cancer Therapeutic Targets Based on the Pathogenesis of Bone Metastases
por: Oyewumi, Moses O., et al.
Publicado: (2014)

Emerging pharmacotherapy for cancer patients with cognitive dysfunction
por: Davis, Justin, et al.
Publicado: (2013)

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma
por: Shih, David J. H., et al.
Publicado: (2020)

Profiles of brain metastases: Prioritization of therapeutic targets
por: Ferguson, Sherise D., et al.
Publicado: (2018)

Targeting lung cancer brain metastases: a narrative review of emerging insights for anaplastic lymphoma kinase (ALK)-positive disease
por: Nelson, Thomas A., et al.
Publicado: (2023)

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Wong, Annick
Publicado: (2017)

RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC
por: Osta, Badi El, et al.
Publicado: (2020)

Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion
por: Chu, Quincy S.
Publicado: (2020)

Targeted Therapies for Brain Metastases from Breast Cancer
por: Venur, Vyshak Alva, et al.
Publicado: (2016)

Radiomics as an emerging tool in the management of brain metastases
por: Nowakowski, Alexander, et al.
Publicado: (2022)

Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives
por: Kotecki, Nuria, et al.
Publicado: (2018)

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
por: De Carlo, Elisa, et al.
Publicado: (2022)

Contraction of T cell richness in lung cancer brain metastases
por: Mansfield, Aaron S., et al.
Publicado: (2018)

Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment
por: Parker, Brittany C., et al.
Publicado: (2013)

State-of-the-art considerations in small cell lung cancer brain metastases
por: Lukas, Rimas V., et al.
Publicado: (2017)

Targeting Brain Metastases in Patients with Melanoma
por: Papadatos-Pastos, Dionysis, et al.
Publicado: (2013)

Emerging Roles of Long Non-Coding RNAs as Drivers of Brain Evolution
por: Zimmer-Bensch, Geraldine
Publicado: (2019)

State of affairs regarding targeted pharmacological therapy of cancers metastasized to the brain
por: Steiger, Hans-Jakob, et al.
Publicado: (2022)

Using lithium as a neuroprotective agent in patients with cancer
por: Khasraw, Mustafa, et al.
Publicado: (2012)

Oncogenic driver mutations in lung cancer
por: Luo, Susan Y, et al.
Publicado: (2013)

Management of brain metastases in elderly patients with lung cancer
por: Socha, Joanna, et al.
Publicado: (2021)

Lung metastases
por: Schueller, G., et al.
Publicado: (2015)

Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis
por: Wei, Joe Q., et al.
Publicado: (2023)

Systemic treatment of non-small cell lung cancer brain metastases
por: Cedrych, Ida, et al.
Publicado: (2016)

Cystic brain metastases in ALK-rearranged non-small cell lung cancer
por: Marta, Guilherme Nader, et al.
Publicado: (2018)

The role of surgical resection in patients with brain metastases
por: Hatiboglu, Mustafa Aziz, et al.
Publicado: (2013)

Whole-Brain Radiotherapy Combined With Anlotinib for Multiple Brain Metastases From Non-small Cell Lung Cancer Without Targetable Driver Mutation: A Single-Arm, Phase II Study
por: Liu, Jianjiang, et al.
Publicado: (2022)

Editorial: Brain and leptomeningeal metastases in lung cancer
por: Vavalà, Tiziana, et al.
Publicado: (2023)

Targeting Oncoimmune Drivers of Cancer Metastasis
por: Kudo-Saito, Chie, et al.
Publicado: (2021)

Management of brain metastases in non-small cell lung cancer without actionable driver mutations—the need to dive deeper in the right ‘pool’
por: Jablonska, Paola Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nmoelu4lgt1g625hig4s776s19